Literature DB >> 17559497

An association between the MICA-A5.1 allele and an increased susceptibility to oral squamous cell carcinoma in Japanese patients.

Shigehiro Tamaki1, Nobuyuki Sanefuzi, Kazuhiko Ohgi, Yuichiro Imai, Masayoshi Kawakami, Kazuhiko Yamamoto, Akiko Ishitani, Katsuhiko Hatake, Tadaaki Kirita.   

Abstract

BACKGROUND: Recently, a new polymorphic gene family called the major histocompatibility complex class I chain-related gene A (MICA) was discovered about 40 kb centromeric to HLA-B gene. The MICA protein, expressed on epithelial cells and many kinds of tumor cells, serves to regulate immune function. The MICA protein is thought to activate immune function on mucosal tissue by binding to NKG2D which is expressed on most natural killer cells, CD8 positive T cells, and gamma delta T cells. An association between MICA gene polymorphisms and the development of oral squamous cell carcinoma (OSCC) has also been reported.
OBJECTIVE: This study was designed to test this association in Japanese patients with OSCC.
METHODS: The (GCT)(n) polymorphisms of the MICA gene was investigated in 123 patients with OSCC and 188 normal controls using polymerase chain reaction amplification and denaturing polyacrylamide gel electrophoresis.
RESULTS: Five alleles, namely A4, A5, A6, A9, and A5.1, were found in both groups. The phenotype frequency of the MICA-A5.1 allele was significantly higher in patients with OSCC when compared with normal controls (OR 1.707, 95% CI 0.76-3.45, P=0.042). Also, the microsatellite frequency of the MICA-A5.1 allele was significantly higher in patients with OSCC compared with normal controls (OR 1.664, 95% CI 0.82-3.42, P=0.021). Lastly, the frequency of the MICA-A5.1 allele was significantly higher in those with lymph node metastasis from OSCC compared with normal controls (OR 2.605, 95% CI 1.14-5.27, P=0.026).
CONCLUSIONS: These results suggest that the MICA-A5.1 allele may be associated with an increased susceptibility to OSCC in Japan.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17559497     DOI: 10.1111/j.1600-0714.2007.00539.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  9 in total

1.  MICA polymorphisms and cancer risk: a meta-analysis.

Authors:  Mengyao Ji; Jun Wang; Lei Yuan; Yunting Zhang; Jixiang Zhang; Weiguo Dong; Xiulan Peng
Journal:  Int J Clin Exp Med       Date:  2015-01-15

2.  A Genome-Wide Association Study Identifies Two Novel Susceptible Regions for Squamous Cell Carcinoma of the Head and Neck.

Authors:  Hongliang Liu; Jian Wang; Robert Yu; Sanjay Shete; Erich M Sturgis; Guojun Li; Kristina R Dahlstrom; Zhensheng Liu; Christopher I Amos; Qingyi Wei
Journal:  Cancer Res       Date:  2020-04-10       Impact factor: 12.701

3.  Soluble MICA and a MICA variation as possible prognostic biomarkers for HBV-induced hepatocellular carcinoma.

Authors:  Vinod Kumar; Paulisally Hau Yi Lo; Hiromi Sawai; Naoya Kato; Atsushi Takahashi; Zhenzhong Deng; Yuji Urabe; Hamdi Mbarek; Katsushi Tokunaga; Yasuhito Tanaka; Masaya Sugiyama; Masashi Mizokami; Ryosuke Muroyama; Ryosuke Tateishi; Masao Omata; Kazuhiko Koike; Chizu Tanikawa; Naoyuki Kamatani; Michiaki Kubo; Yusuke Nakamura; Koichi Matsuda
Journal:  PLoS One       Date:  2012-09-14       Impact factor: 3.240

Review 4.  Regulation of immune cell function and differentiation by the NKG2D receptor.

Authors:  Biljana Zafirova; Felix M Wensveen; Maja Gulin; Bojan Polić
Journal:  Cell Mol Life Sci       Date:  2011-09-06       Impact factor: 9.261

5.  Association between MICA polymorphisms, s-MICA levels, and pancreatic cancer risk in a population-based case-control study.

Authors:  Guillaume Onyeaghala; John Lane; Nathan Pankratz; Heather H Nelson; Bharat Thyagarajan; Bruce Walcheck; Kristin E Anderson; Anna E Prizment
Journal:  PLoS One       Date:  2019-06-05       Impact factor: 3.240

Review 6.  Role of Polymorphisms of NKG2D Receptor and Its Ligands in Acute Myeloid Leukemia and Human Stem Cell Transplantation.

Authors:  Alena Machuldova; Monika Holubova; Valentina S Caputo; Miroslava Cedikova; Pavel Jindra; Lucie Houdova; Pavel Pitule
Journal:  Front Immunol       Date:  2021-03-30       Impact factor: 7.561

7.  Major Histocompatibility Complex Class I-Related Chain A (MICA) Allelic Variants Associate With Susceptibility and Prognosis of Gastric Cancer.

Authors:  Karen Toledo-Stuardo; Carolina H Ribeiro; Andrea Canals; Marcela Morales; Valentina Gárate; Jose Rodríguez-Siza; Samantha Tello; Marco Bustamante; Ricardo Armisen; Douglas J Matthies; Gerald Zapata-Torres; Patricio González-Hormazabal; María Carmen Molina
Journal:  Front Immunol       Date:  2021-03-31       Impact factor: 7.561

8.  The MICA-129Met/Val dimorphism affects plasma membrane expression and shedding of the NKG2D ligand MICA.

Authors:  Antje Isernhagen; Daniela Schilling; Sebastian Monecke; Pranali Shah; Leslie Elsner; Lutz Walter; Gabriele Multhoff; Ralf Dressel
Journal:  Immunogenetics       Date:  2015-11-19       Impact factor: 2.846

Review 9.  The Biological Influence and Clinical Relevance of Polymorphism Within the NKG2D Ligands.

Authors:  Jianmin Zuo; Fiyaz Mohammed; Paul Moss
Journal:  Front Immunol       Date:  2018-08-16       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.